DK122391A - Terapeutisk aktiv, substitueret benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme - Google Patents
Terapeutisk aktiv, substitueret benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme Download PDFInfo
- Publication number
- DK122391A DK122391A DK122391A DK122391A DK122391A DK 122391 A DK122391 A DK 122391A DK 122391 A DK122391 A DK 122391A DK 122391 A DK122391 A DK 122391A DK 122391 A DK122391 A DK 122391A
- Authority
- DK
- Denmark
- Prior art keywords
- acceptable salts
- physiologically acceptable
- substituted
- procedure
- therapeutic activity
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- BPNFLVVPRJYSTN-UHFFFAOYSA-N 6-chloro-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1h-benzimidazole Chemical compound COC1=CC=NC(CS(=O)C=2NC3=CC=C(Cl)C=C3N=2)=C1OC BPNFLVVPRJYSTN-UHFFFAOYSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000004211 gastric acid Anatomy 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8804628 | 1988-12-22 | ||
| SE19888804628A SE8804628D0 (sv) | 1988-12-22 | 1988-12-22 | New compounds |
| SE8900741 | 1989-03-13 | ||
| PCT/SE1989/000741 WO1990006926A1 (en) | 1988-12-22 | 1989-12-20 | Therapeutically active substituted benzimidazole and process for its preparation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK122391D0 DK122391D0 (da) | 1991-06-21 |
| DK122391A true DK122391A (da) | 1991-06-24 |
| DK170801B1 DK170801B1 (da) | 1996-01-22 |
Family
ID=20374309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK122391A DK170801B1 (da) | 1988-12-22 | 1991-06-21 | Terapeutisk aktivt, substitueret benzimidazolderivat og fysiologisk acceptable salte og optiske enantiomerer heraf samt fremgangsmåde til fremstilling af samme, farmaceutisk præparat indeholdende benzimidazolderivatet, anvendelse af derivatet til fremstilling af et lægemiddel til hæmning af mavesyresekretionen hos pattedyr og til behandling af inflammatoriske mavetarmkanallidelser hos pattedyr sam |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US5019584A (da) |
| EP (1) | EP0451188B1 (da) |
| JP (1) | JP2793907B2 (da) |
| CN (1) | CN1028232C (da) |
| AT (1) | ATE110379T1 (da) |
| AU (1) | AU636866B2 (da) |
| CA (1) | CA2005987C (da) |
| DD (1) | DD296077A5 (da) |
| DE (1) | DE68917738T2 (da) |
| DK (1) | DK170801B1 (da) |
| FI (1) | FI913036A7 (da) |
| GR (1) | GR1000318B (da) |
| HU (1) | HUT57203A (da) |
| IE (1) | IE64850B1 (da) |
| IL (1) | IL92797A (da) |
| LT (1) | LT3981B (da) |
| LV (1) | LV10268B (da) |
| NO (1) | NO178338C (da) |
| PH (1) | PH27257A (da) |
| PT (1) | PT92647B (da) |
| RO (1) | RO110496B1 (da) |
| RU (1) | RU2070199C1 (da) |
| SE (1) | SE8804628D0 (da) |
| WO (1) | WO1990006926A1 (da) |
| YU (1) | YU242589A (da) |
| ZA (1) | ZA899796B (da) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE184602T1 (de) * | 1990-06-20 | 1999-10-15 | Astra Ab | Dialkoxypyridinylbenzimidazolderivate, verfahren zur herstellung und ihre pharmazeutische verwendung |
| NZ244301A (en) * | 1991-09-20 | 1994-08-26 | Merck & Co Inc | Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds |
| US6016044A (en) * | 1995-09-11 | 2000-01-18 | Alaris Medical Systems, Inc. | Open-loop step motor control system |
| US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| US6645988B2 (en) * | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
| US6699885B2 (en) | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
| RU2144823C1 (ru) * | 1998-11-20 | 2000-01-27 | Научно-исследовательский институт фармакологии Томского научного центра РАМН | Лекарственное средство, обладающее слабительным действием |
| JP2005521662A (ja) * | 2002-01-25 | 2005-07-21 | サンタラス インコーポレイティッド | プロトンポンプ阻害剤の経粘膜送達 |
| AU2003224781A1 (en) * | 2002-03-26 | 2003-10-13 | Dr. Reddy's Laboratories Limited | Crystalline forms of rabeprazole sodium |
| WO2004073654A2 (en) * | 2003-02-20 | 2004-09-02 | Santarus, Inc. | A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained supression of gastric acid |
| CA2531566C (en) * | 2003-07-18 | 2013-05-07 | Santarus, Inc. | Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders |
| US8993599B2 (en) * | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| MXPA06000529A (es) * | 2003-07-18 | 2006-08-11 | Santarus Inc | Formulaciones farmaceuticas utiles para inhibir la secrecion de acido y metodos para elaborarlas y utilizarlas. |
| US20070292498A1 (en) * | 2003-11-05 | 2007-12-20 | Warren Hall | Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers |
| US8906940B2 (en) * | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US8815916B2 (en) * | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US20090092658A1 (en) * | 2007-10-05 | 2009-04-09 | Santarus, Inc. | Novel formulations of proton pump inhibitors and methods of using these formulations |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE418966B (sv) | 1974-02-18 | 1981-07-06 | Haessle Ab | Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan |
| SE416649B (sv) | 1974-05-16 | 1981-01-26 | Haessle Ab | Forfarande for framstellning av foreningar som paverkar magsyrasekretionen |
| IN148930B (da) | 1977-09-19 | 1981-07-25 | Hoffmann La Roche | |
| SE7804231L (sv) | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
| US4359465A (en) | 1980-07-28 | 1982-11-16 | The Upjohn Company | Methods for treating gastrointestinal inflammation |
| CH644116A5 (de) | 1980-08-21 | 1984-07-13 | Hoffmann La Roche | Imidazolderivate. |
| US4331671A (en) * | 1981-01-09 | 1982-05-25 | Sterling Drug Inc. | 5-(Pyridinyl)-1H-benzimidazoles and 1-hydroxy-6-(pyridinyl)-1H-benzimidazoles and their cardiotonic use |
| HU195220B (en) | 1983-05-03 | 1988-04-28 | Byk Gulden Lomberg Chem Fqb | Process for production of new fluor-alkoxi-benzimidasole-derivatives and medical compositions containig them |
| JPS6150979A (ja) | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
| JPS6150978A (ja) | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
| SE8500996D0 (sv) * | 1985-03-01 | 1985-03-01 | Haessle Ab | Method of treatment |
| US4738975A (en) * | 1985-07-02 | 1988-04-19 | Takeda Chemical Industries, Ltd. | Pyridine derivatives, and use as anti-ulcer agents |
| GB8610607D0 (en) * | 1986-04-30 | 1986-06-04 | Smith Kline French Lab | Chemical compounds |
| FR2593178B1 (fr) * | 1986-01-20 | 1988-04-29 | Esteve Labor Dr | Derives de 2-benzimidazolylalkylthio (ou sulfinyle ou sulfonyle) leur preparation et leur application en tant que medicaments. |
| EP0338066A1 (en) * | 1987-10-30 | 1989-10-25 | Aktiebolaget Hässle | 2-pyridinylmethyl (sulfinyl or thio)benzimidazoles for treatment of diseases related to bone loss |
-
1988
- 1988-12-22 SE SE19888804628A patent/SE8804628D0/xx unknown
-
1989
- 1989-12-18 IE IE404989A patent/IE64850B1/xx not_active IP Right Cessation
- 1989-12-19 CA CA002005987A patent/CA2005987C/en not_active Expired - Lifetime
- 1989-12-19 PH PH39730A patent/PH27257A/en unknown
- 1989-12-19 GR GR890100834A patent/GR1000318B/el unknown
- 1989-12-19 IL IL9279789A patent/IL92797A/en not_active IP Right Cessation
- 1989-12-20 JP JP2501538A patent/JP2793907B2/ja not_active Expired - Fee Related
- 1989-12-20 HU HU901085A patent/HUT57203A/hu unknown
- 1989-12-20 EP EP90901080A patent/EP0451188B1/en not_active Expired - Lifetime
- 1989-12-20 WO PCT/SE1989/000741 patent/WO1990006926A1/en not_active Ceased
- 1989-12-20 AT AT90901080T patent/ATE110379T1/de not_active IP Right Cessation
- 1989-12-20 DD DD89335979A patent/DD296077A5/de not_active IP Right Cessation
- 1989-12-20 RU SU894895822A patent/RU2070199C1/ru active
- 1989-12-20 US US07/454,046 patent/US5019584A/en not_active Expired - Lifetime
- 1989-12-20 FI FI913036A patent/FI913036A7/fi not_active Application Discontinuation
- 1989-12-20 RO RO147868A patent/RO110496B1/ro unknown
- 1989-12-20 AU AU48176/90A patent/AU636866B2/en not_active Ceased
- 1989-12-20 DE DE68917738T patent/DE68917738T2/de not_active Expired - Fee Related
- 1989-12-20 ZA ZA899796A patent/ZA899796B/xx unknown
- 1989-12-21 YU YU02425/89A patent/YU242589A/xx unknown
- 1989-12-21 PT PT92647A patent/PT92647B/pt not_active IP Right Cessation
- 1989-12-21 CN CN89109588A patent/CN1028232C/zh not_active Expired - Fee Related
-
1991
- 1991-06-20 NO NO912416A patent/NO178338C/no unknown
- 1991-06-21 DK DK122391A patent/DK170801B1/da not_active IP Right Cessation
-
1993
- 1993-06-28 LV LVP-93-692A patent/LV10268B/lv unknown
- 1993-12-30 LT LTIP1722A patent/LT3981B/lt not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK122291A (da) | Benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme | |
| DK122391A (da) | Terapeutisk aktiv, substitueret benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme | |
| NO882732L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
| NO904694L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater. | |
| NO901684L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater. | |
| NO167202C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive (1h-imidazol-1-ylmetyl)-substituerte benzimidazolderivater. | |
| FI885460L (fi) | Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi | |
| NO871295D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
| NO883122L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater. | |
| NO167204C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive diacylderivater av 4-(trialkylbenzyl)-piperazinylforbindelser. | |
| NO870049L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
| NO178336C (no) | Analogifremgangsmåte for fremstilling av en terapeutisk aktiv benzimidazolforbindelse og mellomprodukter | |
| NO167734C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater. | |
| NO902710D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive r(-) 3-kinuklidinol-derivater. | |
| NO874850D0 (no) | Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav. | |
| NO884175L (no) | Fremgangsmaate for fremstilling av terapeutiske aktive heterocykliske derivater. | |
| NO913644D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
| NO172491C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater | |
| NO900972L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater. | |
| NO874780D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater. | |
| NO900942D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater. | |
| NO167381C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktiv (e)-2-(p-fluorfenethyl)-3-fluorallylamin. | |
| NO172120C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive isoxazoler | |
| NO167511C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater. | |
| NO890502D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive etanolamin-derivater. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B1 | Patent granted (law 1993) | ||
| PBP | Patent lapsed |